1. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression. Issue 1 (12th January 2021) Authors: Natoli, Marina; Gallon, John; Lu, Haonan; Amgheib, Ala; Pinato, David J; Mauri, Francesco A; Marafioti, Teresa; Akarca, Ayse U; Ullmo, Ines; Ip, Jacey; Aboagye, Eric O; Brown, Robert; Karadimitris, Anastasios; Ghaem-Maghami, Sadaf Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression. Issue 1 (12th January 2021) Authors: Natoli, Marina; Gallon, John; Lu, Haonan; Amgheib, Ala; Pinato, David J; Mauri, Francesco A; Marafioti, Teresa; Akarca, Ayse U; Ullmo, Ines; Ip, Jacey; Aboagye, Eric O; Brown, Robert; Karadimitris, Anastasios; Ghaem-Maghami, Sadaf Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression. Issue 1 (12th January 2021) Authors: Natoli, Marina; Gallon, John; Lu, Haonan; Amgheib, Ala; Pinato, David J; Mauri, Francesco A; Marafioti, Teresa; Akarca, Ayse U; Ullmo, Ines; Ip, Jacey; Aboagye, Eric O; Brown, Robert; Karadimitris, Anastasios; Ghaem-Maghami, Sadaf Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗